Abstract Topics
View Abstract Topics Below and Start Preparing Your Abstract
Diagnosis
- Cytomorphology and Histology
- Flow Cytometry
- Molecular Aberrations (Cytogenetic, Genetic, Gene Expression)
Epidemiology
Outcome Research (Including Quality of Life) and Health Economics
- Cost of Care
- Patient-Reported Outcomes & Quality of Life
- Efficacy Outcome Measures
MDS Biology and Pathogenesis
- Clonal Diversity & Evolution
- MDS Mouse Models (GEMMS, PDX)
- Spliceosome Machinery
- Gene Expression Profiling and Epigenetic Deregulation
- Immune Deregulation / Inflammation
- Microenvironment and Stem Cell Niche
Nurses Program (For Poster Presentation Only)
Prognosis
- Prognostic Factors of Outcome and Risk Assessment
- Predictive Factors of Response to Treatment
Specific Disease Entities
- CHIP, CCUS, ICUS
- MDS in Childhood
- Hereditary MDS Including Predisposition Syndromes
- MDS with Ring Sideroblasts/SF3B1
- Chronic Myelomonocytic Leukemia and Overlap Syndromes (MDS – MPN)
- MDS with Deletion 5q
- Treatment-Related MDS
- VEXAS/ VEXAS-Like Disease
Treatment
- Current Treatment Options – Higher Risk MDS
- Current Treatment Options – Lower Risk MDS
- Current Treatment Options -Immunosuppressive Therapy
- New Developments – Preclinical Studies
- New Developments – Phase I Studies
- Clinical Trials – Phase II-III
- Allogeneic Hematopoietic Cell Transplantation and Bridging to Transplantation
- Allogeneic Hematopoietic Cell Transplantation -Post-Transplantation Treatment
- Observational Studies
- Supportive Care, Transfusion Medicine and MDS, Iron Overload
- Supportive Care, Geriatric Issues and MDS